Tyler Bussian
Stock Analyst at Brookline Capital
(0.12)
# 4,451
Out of 5,182 analysts
5
Total ratings
25%
Success rate
-29.08%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tyler Bussian
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COCH Envoy Medical | Initiates: Buy | $9 | $0.63 | +1,319.11% | 1 | Oct 14, 2024 | |
| CRVO CervoMed | Initiates: Buy | $63 | $3.71 | +1,598.11% | 1 | Jul 8, 2024 | |
| IMUX Immunic | Initiates: Buy | $100 | $10.75 | +830.23% | 1 | Apr 5, 2024 | |
| ANVS Annovis Bio | Downgrades: Hold | $9 | $1.85 | +386.49% | 2 | Feb 28, 2024 |
Envoy Medical
Oct 14, 2024
Initiates: Buy
Price Target: $9
Current: $0.63
Upside: +1,319.11%
CervoMed
Jul 8, 2024
Initiates: Buy
Price Target: $63
Current: $3.71
Upside: +1,598.11%
Immunic
Apr 5, 2024
Initiates: Buy
Price Target: $100
Current: $10.75
Upside: +830.23%
Annovis Bio
Feb 28, 2024
Downgrades: Hold
Price Target: $9
Current: $1.85
Upside: +386.49%